Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

69.92
+0.53000.76%
Post-market: 69.920.00000.00%16:59 EDT
Volume:1.40M
Turnover:97.71M
Market Cap:9.72B
PE:-9.73
High:71.05
Open:70.64
Low:68.92
Close:69.39
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.74
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-56.03
PE(LYR):-10.69

Loading ...

Cytokinetics Inc : RBC Raises Target Price to $119 From $101

THOMSON REUTERS
·
May 06

Cytokinetics Inc : Needham Raises Target Price to $102 From $85

THOMSON REUTERS
·
May 06

Cytokinetics Earnings Call Highlights Launch, Trial Wins

TIPRANKS
·
May 06

Cytokinetics EVP R&D Malik Fady Ibraham disposes 3,500 shares worth $270,795

Reuters
·
May 06

Cytokinetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

BRIEF-Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price Of $650 Million - SEC Filing

Reuters
·
May 06

Cytokinetics Inc - Offers Common Stock With Aggregate Public Offering Price of $650 Mln - SEC Filing

THOMSON REUTERS
·
May 06

Cytokinetics plans $650 million common stock offering

Reuters
·
May 06

Earnings Flash (CYTK) Cytokinetics Posts Q1 Loss $1.67, vs. FactSet Est of $1.65 Loss

MT Newswires Live
·
May 06

Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline

TIPRANKS
·
May 06

Cytokinetics Q1 revenue jumps on MYQORZO launch

Reuters
·
May 06

Cytokinetics director Wendell Wierenga sells 4,032 shares for $302,400

Reuters
·
May 06

Cytokinetics Q1 EPS $(1.67) Misses $(1.64) Estimate, Sales $19.355M Beat $8.518M Estimate.

Benzinga Earnings
·
May 06

Cytokinetics CFO Sung Lee sells 23,906 shares for $1.84 million

Reuters
·
May 06

Cytokinetics Inc - Announces Proposed $650 Mln Common Stock Offering

THOMSON REUTERS
·
May 06

Cytokinetics EVP, Chief Commercial Officer Andrew Callos disposes 11,333 shares for $875,372.25

Reuters
·
May 06

BRIEF-Cytokinetics Q1 Basic EPS USD -1.67

Reuters
·
May 06

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 06

Cytokinetics Is Maintained at Buy by Needham

Dow Jones
·
May 06

Cytokinetics Shares Surge Over 20% on Positive Heart Drug Trial Results

Stock News
·
May 05